Keyphrases
Granulocyte Colony-stimulating Factor (G-CSF)
100%
Fibroblast Growth Factor Receptor 1 (FGFR1)
100%
AZD4547
100%
Fibroblast Growth Factor Receptor Inhibitor
100%
Breast Cancer Growth
100%
Osteoprotegerin
100%
Bone Microenvironment
100%
Metastatic Bone
100%
Osteoblast
33%
Stromal Cells
22%
Osteoclast
22%
Osteoclastogenesis
22%
Breast Cancer Cells
22%
Breast Cancer
22%
Receptor Tyrosine Kinase Inhibitor
22%
Growth Factor Receptor Tyrosine Kinase
22%
Bone Metastasis
22%
Receptor-mediated
11%
Clinical Trials
11%
Metastasis
11%
Biologically Active
11%
Mouse Model
11%
Bone Marrow-derived Monocytes
11%
Culture Supernatant
11%
Receptor Targets
11%
Cancer Types
11%
Tyrosine Kinase Inhibitor
11%
Murine Bone Marrow
11%
In Vivo Analysis
11%
MDA-MB-231 Cells
11%
Mediated Interaction
11%
Metastasizing
11%
Fibroblast Growth Factor Receptor Signaling
11%
Stromal Compartment
11%
Activated Fibroblasts
11%
Tumor Compartments
11%
Tumor-induced Osteolysis
11%
Orthotopic Breast Cancer
11%
Breast Cancer Bone Metastasis
11%
Medicine and Dentistry
Breast Cancer
100%
Osteoclast Differentiation Factor
100%
Cancer Growth
100%
Azd 4547
100%
Fibroblast Growth Factor Receptor
100%
Colony Stimulating Factor 1
100%
Osteoprotegerin
100%
Osteoblast
25%
Tyrosine-Kinase Inhibitor
25%
Bone Metastasis
25%
Cancer Cell
16%
Neoplasm
16%
Malignant Neoplasm
16%
Osteoclastogenesis
16%
Osteoclast
16%
Stromal Cell
16%
Protein Tyrosine Kinase
16%
Metastatic Carcinoma
8%
In Vitro
8%
Osteolysis
8%
Clinical Trial
8%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Osteoclast Differentiation Factor
100%
Cancer Growth
100%
Fibroblast Growth Factor Receptor
100%
Osteoprotegerin
100%
Colony Stimulating Factor 1
100%
Azd 4547
100%
Protein Tyrosine Kinase Inhibitor
25%
Bone Metastasis
25%
Neoplasm
16%
Malignant Neoplasm
16%
Protein Tyrosine Kinase
16%
Clinical Trial
8%
Mouse Model
8%
Biochemistry, Genetics and Molecular Biology
RANKL
100%
Growth Factor Receptor Inhibitor
100%
Fibroblast Growth Factor Receptor
100%
Osteoprotegerin
100%
Macrophage Colony-Stimulating Factor
100%
Osteoblast
25%
Stromal Cell
16%
Cancer Cell
16%
Osteoclast
16%
Osteoclastogenesis
16%
Receptor Tyrosine Kinase Inhibitors
16%
Osteolysis
8%
Clinical Trial
8%
Mouse Model
8%
Tyrosine Kinase Inhibitor
8%
Immunology and Microbiology
Fibroblast Growth Factor
100%
RANKL
100%
Osteoprotegerin
100%
Macrophage Colony-Stimulating Factor
100%
Osteoblast
27%
Cancer Cell
18%
Osteoclast
18%
Osteoclastogenesis
18%
Mouse Model
9%
Osteolysis
9%
Fibroblast Growth Factor 6
9%